Literature DB >> 8602791

Apoptosis of retinal ganglion cells in anterior ischemic optic neuropathy.

L A Levin1, A Louhab.   

Abstract

We identified retinal ganglion cells undergoing apoptosis, a form of programmed cell death, in an eye of a 70-year-old man with anterior ischemic optic neuropathy. The TUNEL (terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate-biotin end nick labeling) staining and the presence of condensed, fragmented nuclear bodies were used to identify apoptotic cells. Examination of TUNEL-stained retinal sections revealed occasional cells in the ganglion cell layer with pyknotic nuclei and brown reaction product, representing positive staining for chromosomal DNA breaks. Positive cells were sparsely distributed, consistent with the limited time in which apoptotic cells are identifiable before they are removed. The most likely explanation for these results is that injury to the retinal ganglion cell axon induces apoptosis. To our knowledge, this is the first report of human retinal ganglion cell apoptosis in an acute optic neuropathy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8602791     DOI: 10.1001/archopht.1996.01100130484027

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  41 in total

1.  Programmed cell death-1 is expressed in large retinal ganglion cells and is upregulated after optic nerve crush.

Authors:  Wei Wang; Ann Chan; Yu Qin; Jacky M K Kwong; Joseph Caprioli; Ralph Levinson; Ling Chen; Lynn K Gordon
Journal:  Exp Eye Res       Date:  2015-08-13       Impact factor: 3.467

2.  Simultaneous labeling of projecting neurons and apoptotic state.

Authors:  Steve M Nguyen; Christopher J Lieven; Leonard A Levin
Journal:  J Neurosci Methods       Date:  2006-12-20       Impact factor: 2.390

3.  Study of effects of antiglaucoma eye drops on N-methyl-D-aspartate-induced retinal damage.

Authors:  Tomomi Metoki; Hiroshi Ohguro; Ikuyo Ohguro; Kazuhisa Mamiya; Tadashi Ito; Mitsuru Nakazawa
Journal:  Jpn J Ophthalmol       Date:  2005 Nov-Dec       Impact factor: 2.447

4.  Choroidal Thickness in Nonarteritic Anterior Ischaemic Optic Neuropathy: A Study with Optical Coherence Tomography.

Authors:  Arnaldo Dias-Santos; Joana Ferreira; Luís Abegão Pinto; André Vicente; Rita Anjos; Ana Cabugueira; Rita Flores; João Paulo Cunha
Journal:  Neuroophthalmology       Date:  2014-06-27

5.  Glutathione-S-Transferase Deletions and Non-arteritic Anterior Ischemic Optic Neuropathy.

Authors:  Wencui Wan; Tao Peng; Xuemin Jin; Qiuming Li; Fengyan Zhang; Guangying Zheng; Yong Lv; Guangming Wan; Yu Zhu
Journal:  Mol Neurobiol       Date:  2015-05-20       Impact factor: 5.590

6.  Y-27632, a Rho-associated protein kinase inhibitor, attenuates neuronal cell death after transient retinal ischemia.

Authors:  Akira Hirata; Masaru Inatani; Yasuya Inomata; Naoko Yonemura; Takahiro Kawaji; Megumi Honjo; Hidenobu Tanihara
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-08-31       Impact factor: 3.117

7.  Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin.

Authors:  A J Barber; E Lieth; S A Khin; D A Antonetti; A G Buchanan; T W Gardner
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

8.  Rodent anterior ischemic optic neuropathy (rAION) induces regional retinal ganglion cell apoptosis with a unique temporal pattern.

Authors:  Bernard J Slater; Zara Mehrabian; Yan Guo; Allan Hunter; Steven L Bernstein
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-08       Impact factor: 4.799

9.  Increased expression of IRE1alpha and stress-related signal transduction proteins in ischemia-reperfusion injured retina.

Authors:  Natsuyo Hata; Toshiyuki Oshitari; Akiko Yokoyama; Yoshinori Mitamura; Shuichi Yamamoto
Journal:  Clin Ophthalmol       Date:  2008-12

10.  Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischaemic optic neuropathy.

Authors:  N R Miller; A C Arnold
Journal:  Eye (Lond)       Date:  2014-07-04       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.